← Open Payments lookup

JAMES MARCZAK: Open Payments

NPI 1720123805 · GLENDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,614 in 77 payments from 16 companies in 2025. Trend: 2023 $1,202 · 2024 $1,343 · 2025 $2,614

Food & beverage: $2,614
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP12$1,254
ABBVIE INC.15$328
Novo Nordisk Inc13$287
Amgen Inc.16$242
PFIZER INC.6$196
Axsome Therapeutics, Inc.2$63
Eisai Inc.2$62
Abbott Laboratories2$37
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$31
Medtronic, Inc.1$24

Products named: BREZTRI, AIRSUPRA, VRAYLAR, Ozempic, REPATHA, TEZSPIRE, NURTEC ODT, OTEZLA.

Industry payments across AZ — which companies pay providers there.